Integral Health Asset Management, LLC

CIK 1773206 · View on SEC EDGAR ↗

Portfolio value QoQ: +21.1% 13F does not disclose cash

Top 10 holdings weight44.81%

Top 25 holdings weight68.68%

Positions above 1%29

Effective number of positions30.6

Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)

Turnover Q2 2026: 25.34% Est. buys $767,853,150 · sells $585,729,150

Median holding: 2.0 quarters Tracked Q1 2025–Q2 2026 · 49.7% still held

New positions31

Increased23

Decreased21

Closed25

Put-notional exposure: 2.2% puts 13F reports option positions at underlying notional value — may include hedges, not necessarily bearish bets

Portfolio value $2.5B #1,388 of 9,339 by 13F value · top 14.9%

Positions 92

As of June 30, 2026 Data as of Q2 2026

Performance vs S&P 500

Tracked Q1 2025–Q2 2026 +77.2%

S&P 500 total return (same window) +37.0%

Excess return +40.2%

Annualized: +58.1% · S&P 500: +28.7%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 99.6% · Options excluded: 5.3%

Sector breakdown

Healthcare 98.2%

Other/Unmapped 1.8%

Full portfolio 92 positions

				Type		Streak
RVMD Revolution Medicines, Inc. - Common Stock	$280,920,000	11.10%	1,500,000		$135,045,000
INSM Insmed Incorporated - Common Stock	$170,592,000	6.74%	1,600,000		$-74,688,000	Up ×2
CYTK Cytokinetics, Incorporated - Common Stock	$136,304,000	5.38%	1,600,000		$30,848,000
CVS CVS Health Corporation Common Stock	$113,795,000	4.49%	1,100,000		$103,022,000	Up ×1
EWTX Edgewise Therapeutics, Inc. - Common Stock	$81,260,000	3.21%	2,000,000		$30,860,000	Up ×2
VERA Vera Therapeutics, Inc. - Class A Common Stock	$75,092,500	2.97%	1,750,000		$10,724,500	Up ×1
AXSM Axsome Therapeutics, Inc. - Common Stock	$73,431,000	2.90%	300,000		$67,515,300	Up ×1
CAH Cardinal Health, Inc. Common Stock	$71,268,000	2.81%	300,000		$14,214,300	Up ×3
ROIV Roivant Sciences Ltd. - Common Shares	$70,780,000	2.80%	2,000,000		$15,380,000
RYTM Rhythm Pharmaceuticals, Inc. - Common Stock	$61,066,500	2.41%	550,000		$8,884,500	Down ×1
EW Edwards Lifesciences Corporation Common Stock	$56,537,500	2.23%	625,000		$42,923,900	Up ×1
RVMD Revolution Medicines, Inc. - Common Stock	$56,184,000	2.22%	300,000	Put option	$-16,753,500	Down ×1
ALHC Alignment Healthcare, Inc. - Common Stock	$47,620,000	1.88%	2,000,000		$2,248,500	Down ×1
MRK Merck & Company, Inc. Common Stock (new)	$44,975,000	1.78%	350,000		$-6,148,250	Down ×1
DGX Quest Diagnostics Incorporated Common Stock	$42,390,000	1.67%	200,000		$30,631,200	Up ×1
QURE uniQure N.V. - Ordinary Shares	$41,454,000	1.64%	900,000		$26,739,000
SRRK Scholar Rock Holding Corporation - Common Stock	$41,250,000	1.63%	750,000		$16,670,000	Up ×3
BSX Boston Scientific Corporation Common Stock	$38,412,000	1.52%	900,000		$3,899,500	Up ×2
BTSG BrightSpring Health Services, Inc. - Common Stock	$38,357,000	1.52%	550,000		$-14,905,500	Down ×1
ABT Abbott Laboratories Common Stock	$36,296,000	1.43%	400,000			Up ×1
UNH UnitedHealth Group Incorporated Common Stock (DE)	$35,328,550	1.40%	85,000
LFST LifeStance Health Group, Inc. - Common Stock	$32,130,000	1.27%	3,000,000		$4,739,000	Down ×1
NVS Novartis AG Common Stock	$31,344,000	1.24%	200,000		$-6,843,500	Down ×1
TNGX Tango Therapeutics, Inc. - Common Stock	$31,260,000	1.23%	1,000,000		$21,846,000	Up ×2
THC Tenet Healthcare Corporation Common Stock	$30,868,200	1.22%	165,000
SYRE Spyre Therapeutics, Inc. - Common Stock	$28,853,500	1.14%	325,000			Up ×1
NVO Novo Nordisk A/S Common Stock	$28,764,000	1.14%	600,000			Up ×1
DFTX Definium Therapeutics, Inc. - Common Shares	$25,872,000	1.02%	550,000		$18,312,000	Up ×1
NBIX Neurocrine Biosciences, Inc. - Common Stock	$25,281,000	1.00%	150,000		$5,520,000
REGN Regeneron Pharmaceuticals, Inc. - Common Stock	$24,941,600	0.99%	40,000		$-40,732,800	Down ×2
IONS Ionis Pharmaceuticals, Inc. - Common Stock	$23,787,000	0.94%	300,000	Call option		Up ×1
BIIB Biogen Inc. - Common Stock	$21,606,000	0.85%	100,000		$10,606,200	Up ×1
TVTX Travere Therapeutics, Inc. - Common Stock	$21,303,750	0.84%	375,000			Up ×1
LNTH Lantheus Holdings, Inc. - Common Stock	$21,078,600	0.83%	190,000		$11,597,350	Up ×2
GKOS Glaukos Corporation Common Stock	$20,964,000	0.83%	150,000		$2,123,500	Down ×2
ORIC Oric Pharmaceuticals, Inc. - Common Stock	$20,577,000	0.81%	1,900,000		$2,839,000	Up ×3
BBIO BridgeBio Pharma, Inc. - Common Stock	$20,482,000	0.81%	275,000		$60,500
VRTX Vertex Pharmaceuticals Incorporated - Common Stock	$19,869,200	0.78%	40,000		$2,007,600
ALMS Alumis Inc. - Common Stock	$19,698,000	0.78%	700,000		$2,074,000	Down ×1
ELV Elevance Health, Inc. Common Stock	$19,336,500	0.76%	50,000		$-2,619,750	Down ×1
CNC Centene Corporation Common Stock	$19,257,000	0.76%	300,000		$-2,024,000	Down ×1
ERAS Erasca, Inc. - Common Stock	$18,320,000	0.72%	1,000,000		$6,994,000	Up ×1
LLY Eli Lilly and Company Common Stock	$17,991,450	0.71%	15,000		$4,194,900
ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock	$16,302,000	0.64%	200,000		$-2,508,000	Down ×1
NVST Envista Holdings Corporation Common Stock	$15,810,000	0.62%	600,000		$6,930,500	Up ×1
MDT Medtronic plc. Ordinary Shares	$15,646,000	0.62%	200,000
WAT Waters Corporation Common Stock	$15,001,600	0.59%	40,000
LIVN LivaNova PLC - Ordinary Shares	$14,801,400	0.58%	180,000		$5,267,400	Up ×1
NVO Novo Nordisk A/S Common Stock	$14,382,000	0.57%	300,000	Call option		Up ×1
FBRX Forte Biosciences, Inc. - Common Stock	$14,343,750	0.57%	675,000		$10,458,750	Up ×1
MDGL Madrigal Pharmaceuticals, Inc. - Common Stock	$13,423,750	0.53%	25,000		$337,000
PRAX Praxis Precision Medicines, Inc. - Common Stock	$13,391,600	0.53%	40,000		$504,000
ANRO Alto Neuroscience, Inc. Common Stock	$13,195,000	0.52%	500,000		$1,955,000
MLYS Mineralys Therapeutics, Inc. - Common Stock	$12,141,000	0.48%	450,000		$-8,176,500	Down ×1
XENE Xenon Pharmaceuticals Inc. - Common Shares	$12,072,000	0.48%	200,000		$442,000
Unknown issuer (CUSIP: K08588103)	$12,002,400	0.47%	45,000			Up ×1
ACHC Acadia Healthcare Company, Inc. - Common Stock	$11,812,000	0.47%	400,000		$7,134,000	Up ×1
IRTC iRhythm Holdings, Inc. - Common Stock	$10,705,500	0.42%	90,000
BHVN Biohaven Ltd. Common Shares	$10,416,000	0.41%	700,000		$1,956,000	Down ×2
BEAM Beam Therapeutics Inc. - Common Stock	$10,296,000	0.41%	300,000		$3,147,000
IART Integra LifeSciences Holdings Corporation - Common Stock	$9,878,000	0.39%	550,000			Up ×1
GEHC GE HealthCare Technologies Inc. - Common Stock	$9,601,500	0.38%	150,000
RGNX REGENXBIO Inc. - Common Stock	$9,584,000	0.38%	800,000		$-2,986,000	Down ×1
ABSI Absci Corporation - Common Stock	$9,272,000	0.37%	800,000			Up ×1
BRKR Bruker Corporation - Common Stock	$9,027,000	0.36%	150,000
COR Cencora, Inc. Common Stock	$8,489,400	0.34%	30,000			Up ×1
COGT Cogent Biosciences, Inc. - Common Stock	$7,740,000	0.31%	200,000		$-5,731,500	Down ×1
ELVN Enliven Therapeutics, Inc. - Common Stock	$7,612,500	0.30%	150,000			Up ×1
BIOA BioAge Labs, Inc. - Common Stock	$7,353,000	0.29%	300,000			Up ×1
JAZZ Jazz Pharmaceuticals plc - Ordinary Shares	$7,229,100	0.29%	30,000			Up ×1
SANA Sana Biotechnology, Inc. - Common Stock	$6,980,000	0.28%	2,000,000		$-2,236,000	Down ×1
IVA Inventiva S.A. - American Depository Shares	$5,745,600	0.23%	1,520,000		$3,525,600	Up ×1
TARA Protara Therapeutics, Inc. - Common Stock	$5,730,000	0.23%	1,500,000		$-3,387,500	Down ×2
ALKS Alkermes plc - Ordinary Shares	$5,239,500	0.21%	100,000
LBRX LB Pharmaceuticals Inc - Common Stock	$4,868,250	0.19%	150,000		$1,169,250
Unknown issuer (CUSIP: 485925101)	$4,770,000	0.19%	200,000			Up ×1
BNTX BioNTech SE - American Depositary Shares	$4,652,500	0.18%	50,000
INSP Inspire Medical Systems, Inc. Common Stock	$4,461,000	0.18%	100,000
TRVI Trevi Therapeutics, Inc. - Common Stock	$3,730,000	0.15%	200,000			Up ×1
IDYA IDEAYA Biosciences, Inc. - Common Stock	$3,727,000	0.15%	100,000			Up ×1
CLDX Celldex Therapeutics, Inc. - Common Stock	$3,721,000	0.15%	100,000			Up ×1
SVRA Savara, Inc. - Common Stock	$3,696,000	0.15%	600,000		$420,000
RLMD Relmada Therapeutics, Inc. - Common Stock	$3,460,000	0.14%	500,000		$328,000	Up ×1
Unknown issuer (CUSIP: 60705V103)	$3,350,000	0.13%	250,000			Up ×1
SION Sionna Therapeutics, Inc. - Common Stock	$3,299,250	0.13%	75,000		$1,294,750	Up ×1
MANE Veradermics, Incorporated Common Stock	$3,073,500	0.12%	25,000			Up ×1
IKT Inhibikase Therapeutics, Inc. - Common Stock	$2,740,500	0.11%	1,350,000		$472,500
RZLT Rezolute, Inc. - Common Stock (NV)	$2,600,000	0.10%	500,000		$-3,500,000	Down ×1
DNLI Denali Therapeutics Inc. - Common Stock	$2,572,000	0.10%	100,000			Up ×1
TENX Tenax Therapeutics, Inc. - Common Stock	$2,429,850	0.10%	167,000		$-240,480
OLMA Olema Pharmaceuticals, Inc. - Common Stock	$1,251,000	0.05%	100,000		$-985,500	Down ×1
AURA Aura Biosciences, Inc. - Common Stock	$1,207,000	0.05%	170,000			Up ×1
No matches

Conviction holdings

Positions increased for 3+ consecutive quarters.

Share counts are as reported in 13F filings (not split-adjusted)

Security	Value	% of portfolio	Streak
CAH	$71,268,000	2.81%	up ×3
SRRK	$41,250,000	1.63%	up ×3
ORIC	$20,577,000	0.81%	up ×3

Biggest new bets

New positions opened this quarter, largest first.

Security	Value	Shares	% of portfolio
ABT	$36,296,000	400,000	1.43%
UNH	$35,328,550	85,000	1.40%
THC	$30,868,200	165,000	1.22%
SYRE	$28,853,500	325,000	1.14%
NVO	$28,764,000	600,000	1.14%
IONS	$23,787,000	300,000	0.94%
TVTX	$21,303,750	375,000	0.84%
MDT	$15,646,000	200,000	0.62%
WAT	$15,001,600	40,000	0.59%
NVO	$14,382,000	300,000	0.57%
Unknown issuer (CUSIP: K08588103)	$12,002,400	45,000	0.47%
IRTC	$10,705,500	90,000	0.42%
IART	$9,878,000	550,000	0.39%
GEHC	$9,601,500	150,000	0.38%
ABSI	$9,272,000	800,000	0.37%

Top movers (QoQ)

Security	Action	Shares Δ	Value Δ
RVMD	Price move only	+0	+$135.0M
INSM	Bought more	+100K	-$74.7M
EW	Bought more	+455K	+$42.9M
REGN	Trimmed	-45K	-$40.7M
EWTX	Bought more	+400K	+$30.9M
CYTK	Price move only	+0	+$30.8M
DGX	Bought more	+140K	+$30.6M
QURE	Price move only	+0	+$26.7M
TNGX	Bought more	+550K	+$21.8M
DFTX	Bought more	+150K	+$18.3M

2 positions hidden — reported move looks larger than the position itself (data completeness check)

Exited positions

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

Security	Quarter	Shares before	Value before	Price since exit
MDT	March 31, 2026	675,000	$64,840,500	10.1%
AZN	June 30, 2026	250,000	$49,305,000	-9.6%
TEVA	March 31, 2026	1,000,000	$31,210,000	30.8%
PEN	March 31, 2026	100,000	$31,091,000	-1.2%
TFX	March 31, 2026	250,000	$30,510,000	13.9%
NAMS	Dec. 31, 2025	1,000,000	$28,440,000	-43.8%
ASND	June 30, 2026	115,000	$26,303,950	-8.8%
ALNY	March 31, 2026	60,000	$23,859,000	-32.3%
IRTC	March 31, 2026	130,000	$23,067,200	2.8%
NVO	Dec. 31, 2025	400,000	$22,196,000	-23.3%
UPB	March 31, 2026	750,000	$20,362,500	-69.6%
THC	March 31, 2026	100,000	$19,872,000	42.3%
GILD	June 30, 2025	175,000	$19,608,750	40.7%
DOCS	March 31, 2026	400,000	$17,712,000	43.3%
FMS	June 30, 2026	775,000	$17,484,000	0.3%
DXCM	Sept. 30, 2025	200,000	$17,458,000	15.8%
TERN	March 31, 2026	425,000	$17,170,000	No longer tracked
UNH	March 31, 2026	50,000	$16,505,500	54.5%
ISRG	June 30, 2026	35,000	$16,134,650	13.7%
ASND	June 30, 2025	100,000	$15,586,000	41.0%
GEHC	Sept. 30, 2025	200,000	$14,814,000	-4.9%
RDNT	March 31, 2026	200,000	$14,270,000	25.9%
TARS	June 30, 2026	200,000	$14,030,000	8.4%
GILD	June 30, 2026	100,000	$13,937,000	23.5%
ELAN	June 30, 2026	550,000	$13,161,500	-8.5%
ACLX	June 30, 2025	200,000	$13,120,000	No longer tracked
ACLX	March 31, 2026	200,000	$13,040,000	No longer tracked
BPMC	June 30, 2025	145,000	$12,833,950	No longer tracked
PFE	Dec. 31, 2025	500,000	$12,740,000	20.6%
DNTH	June 30, 2026	150,000	$12,588,000	-21.2%
MCK	Dec. 31, 2025	15,000	$11,588,100	22.0%
A	Dec. 31, 2025	90,000	$11,551,500	27.2%
DXCM	June 30, 2026	175,000	$10,990,000	15.7%
EXAS	Dec. 31, 2025	200,000	$10,942,000	No longer tracked
SLNO	June 30, 2026	325,000	$10,881,000	No longer tracked
IRON	June 30, 2026	170,000	$10,869,800	1.9%
NRIX	June 30, 2026	700,000	$10,850,000	4.5%
KRYS	June 30, 2025	60,000	$10,818,000	126.6%
COO	June 30, 2026	150,000	$10,725,000	-14.6%
EHC	March 31, 2026	100,000	$10,614,000	28.3%
ETNB	Sept. 30, 2025	1,050,000	$10,311,000	No longer tracked
DYN	Dec. 31, 2025	800,000	$10,120,000	-20.1%
TMO	June 30, 2026	20,000	$9,830,600	34.4%
MLTX	Sept. 30, 2025	200,000	$9,440,000	65.3%
CELC	June 30, 2026	80,000	$9,131,200	-37.6%
CRL	March 31, 2026	45,000	$8,976,600	100.2%
IQV	Dec. 31, 2025	45,000	$8,547,300	23.9%
SNDX	June 30, 2026	350,000	$8,176,000	-38.7%
VKTX	June 30, 2026	250,000	$8,135,000	-37.5%
TEVA	June 30, 2025	500,000	$7,685,000	135.1%
BAX	Sept. 30, 2025	250,000	$7,570,000	11.1%
MASI	June 30, 2025	45,000	$7,497,000	No longer tracked
ACHC	Dec. 31, 2025	300,000	$7,428,000	122.1%
ABBV	Sept. 30, 2025	40,000	$7,424,800	23.4%
INSP	March 31, 2026	75,000	$6,917,250	37.9%
HOLX	Dec. 31, 2025	100,000	$6,749,000	No longer tracked
XENE	June 30, 2025	200,000	$6,710,000	12.9%
BMY	June 30, 2025	100,000	$6,099,000	32.8%
CAPR	June 30, 2026	200,000	$6,080,000	-75.4%
IQV	June 30, 2026	35,000	$5,968,900	44.6%
RNA	June 30, 2025	200,000	$5,904,000	-71.1%
BRKR	March 31, 2026	125,000	$5,888,750	59.4%
VRNA	Sept. 30, 2025	60,000	$5,674,800	No longer tracked
JNJ	Dec. 31, 2025	30,000	$5,562,600	27.5%
ATYR	Sept. 30, 2025	1,050,000	$5,323,500	-77.1%
VKTX	Sept. 30, 2025	200,000	$5,300,000	-7.2%
IQV	June 30, 2025	30,000	$5,289,000	77.3%
PTGX	June 30, 2026	50,000	$5,270,000	12.9%
WAT	Sept. 30, 2025	15,000	$5,235,600	51.3%
EVMN	June 30, 2026	225,000	$5,172,750	-61.6%
PTCT	June 30, 2025	100,000	$5,096,000	24.1%
APLS	March 31, 2026	200,000	$5,024,000	No longer tracked
PHVS	Dec. 31, 2025	200,000	$4,990,000	13.2%
CRSP	Sept. 30, 2025	100,000	$4,864,000	-23.8%
DYN	June 30, 2025	450,000	$4,707,000	64.1%
MNMD	March 31, 2026	350,000	$4,686,500	No longer tracked
LH	June 30, 2025	20,000	$4,654,800	25.3%
BDX	June 30, 2025	20,000	$4,581,200
ZBH	June 30, 2026	50,000	$4,521,000	14.5%
CRNX	June 30, 2025	125,000	$4,192,500	No longer tracked
ESPR	Dec. 31, 2025	1,500,000	$3,975,000	No longer tracked
GMED	June 30, 2025	50,000	$3,660,000	37.9%
EYPT	March 31, 2026	200,000	$3,654,000	-96.9%
BNTX	June 30, 2025	40,000	$3,642,400	-17.2%
RARE	Sept. 30, 2025	100,000	$3,636,000	-48.0%
GPCR	March 31, 2026	50,000	$3,477,500	-56.0%
BBIO	June 30, 2025	100,000	$3,457,000	58.8%
SGHT	March 31, 2026	425,000	$3,370,250	138.5%
CI	June 30, 2025	10,000	$3,290,000	-7.1%
JSPR	Sept. 30, 2025	590,000	$3,274,500	-78.6%
CPRX	Sept. 30, 2025	150,000	$3,255,000	No longer tracked
GOSS	March 31, 2026	1,000,000	$3,100,000	-63.5%
IMCR	June 30, 2026	100,000	$3,015,000	-2.4%
VSTM	June 30, 2025	500,000	$3,015,000	141.9%
MAZE	June 30, 2026	100,000	$2,985,000	3.9%
OSCR	March 31, 2026	200,000	$2,874,000	170.2%
ALKS	Sept. 30, 2025	100,000	$2,861,000	45.4%
RGEN	June 30, 2025	20,000	$2,544,800	42.2%
RCUS	Sept. 30, 2025	300,000	$2,442,000	36.3%
ARWR	June 30, 2025	175,000	$2,229,500	267.2%
MREO	June 30, 2025	800,000	$1,800,000	-89.6%
BCRX	March 31, 2026	200,000	$1,560,000	-19.6%
UNCY	June 30, 2026	225,000	$1,480,500	-17.1%
CABA	June 30, 2025	850,000	$1,177,250	-3.3%
PTNT	June 30, 2025	1,000,000	$582,900
FATE	June 30, 2025	700,000	$553,070	88.4%